COVID-19

Kymera Therapeutics Doses First Patient in Phase 1 Oncology Trial of MDM2 Degrader KT-253

KT-253 is a novel, highly potent and selective heterobifunctional degrader of the MDM2 oncoprotein with a differentiated profile from small…

1 year ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) --  Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology…

1 year ago

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

  Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same…

1 year ago

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period…

1 year ago

SteraMist Unveils Sleek New Website to Enhance User Experience

FREDERICK, Md., May 18, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

1 year ago

Motus GI Announces $3.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

FORT LAUDERDALE, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”),…

1 year ago

Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors

BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…

1 year ago

New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes

Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE…

1 year ago

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health…

1 year ago

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapyMALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE)…

1 year ago